US Stock MarketDetailed Quotes
ORGS Orgenesis
- 0.504
- +0.002+0.40%
Close Apr 25 16:00 ET
17.31MMarket Cap-263P/E (TTM)
0.521High0.500Low11.93KVolume0.510Open0.502Pre Close6.07KTurnover0.04%Turnover RatioLossP/E (Static)34.34MShares1.50052wk High-0.82P/B14.06MFloat Cap0.25052wk Low--Dividend TTM27.90MShs Float16.800Historical High--Div YieldTTM4.16%Amplitude0.250Historical Low0.508Avg Price1Lot Size
About Orgenesis Company
Orgenesis, Inc. is a biotechnology company, which engages in the development, manufacturing, and provision of technologies, and services in the cell and gene therapy industry. It operates through the Morgenesis and Therapies segments. The Morgenesis segment refers to the POCare services. The Therapies segment is involved in therapeutic development operations. The company was founded by Sarah Ferber on June 5, 2008 and is headquartered in Germantown, MD.
Company Profile
SymbolORGS
Company NameOrgenesis
Listing DateMar 13, 2018
Founded2008
CEOMs. Vered Caplan
MarketNASDAQ
Employees146
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address20271 Goldenrod Lane
CityGermantown
ProvinceMaryland
CountryUnited States of America
Zip Code20876
Phone1-480-659-6404
Websitehttp://www.orgenesis.com
Company Executives
- Name
- Position
- Salary
- Vered Caplan
- Chairman of the Board and Chief Executive Officer
- 3.98M
- Victor Miller
- Chief Financial Officer, Principal Accounting Officer, Secretary and Treasurer
- --
- Mario Philips
- Independent Director
- 74.22K
- Ashish Nanda
- Independent Director
- 92.91K
- Yaron Adler
- Independent Director
- 86.42K
- Dr. David Sidransky, M.D.
- Independent Director
- 141.02K
- Guy Yachin
- Independent Director
- 134.52K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg